Russell Investments Group, Ltd. Paratek Pharmaceuticals, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$6.81 - $10.93 $286,183 - $459,322	-42,024 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$6.14 - $8.31 $11,487 - $15,548	1,871 Added 4.66%	42,024 $295,000
Q4 2020 Feb 08, 2021	BUY	$4.58 - $7.14 $183,900 - $286,692	40,153 New	40,153 $250,000
Q1 2018 May 11, 2018	SELL	$12.65 - $18.85 $1.58 Million - $2.35 Million	-124,561 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$17.45 - $25.6 $105,188 - $154,316	6,028 Added 5.09%	124,561 $2.26 Million
Q3 2017 Nov 07, 2017	BUY	$18.9 - $28.2 $2.24 Million - $3.34 Million	118,533	118,533 $2.98 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.